• 4292 Citations
  • 30 h-Index
1993 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Dingwei Ye is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Urinary Bladder Neoplasms Medicine & Life Sciences
Penile Neoplasms Medicine & Life Sciences
Prostate-Specific Antigen Medicine & Life Sciences
Prostatectomy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2019

4 Citations (Scopus)

Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial

Fizazi, K., Tran, N. P., Fein, L., Matsubara, N., Rodriguez-Antolin, A., Alekseev, B. Y., Özgüroğlu, M., Ye, D., Feyerabend, S., Protheroe, A., Sulur, G., Luna, Y., Li, S., Mundle, S. & Chi, K. N., May 1 2019, In : The lancet oncology. 20, 5, p. 686-700 15 p.

Research output: Contribution to journalArticle

Castration
Survival Analysis
Prednisone
Prostatic Neoplasms
Placebos

AMPK Promotes SPOP-Mediated NANOG Degradation to Regulate Prostate Cancer Cell Stemness

Wang, X., Jin, J., Wan, F., Zhao, L., Chu, H., Chen, C., Liao, G., Liu, J., Yu, Y., Teng, H., Fang, L., Jiang, C., Pan, W., Xie, X., Li, J., Lu, X., Jiang, X., Ge, X., Ye, D. & Wang, P., Feb 11 2019, In : Developmental cell. 48, 3, p. 345-360.e7

Research output: Contribution to journalArticle

Phosphorylation
AMP-Activated Protein Kinases
Stem cells
Prostatic Neoplasms
Cells

A multicenter observational study of the real-world use of docetaxel for metastatic castration-resistant prostate cancer in China

He, D., Sun, Z., Guo, J., Zhang, Z., Shan, Y., Ma, L., Li, H., Jin, J., Huang, Y., Xiao, J., Wei, Q. & Ye, D., Jun 1 2019, In : Asia-Pacific Journal of Clinical Oncology. 15, 3, p. 144-150 7 p.

Research output: Contribution to journalArticle

docetaxel
Castration
Multicenter Studies
Observational Studies
China
3 Citations (Scopus)

A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings(Figure presented.)

Chiu, P. K. F., Ng, C. F., Semjonow, A., Zhu, Y., Vincendeau, S., Houlgatte, A., Lazzeri, M., Guazzoni, G., Stephan, C., Haese, A., Bruijne, I., Teoh, J. Y. C., Leung, C. H., Casale, P., Chiang, C. H., Tan, L. G. L., Chiong, E., Huang, C. Y., Wu, H., Nieboer, D. & 3 others, Ye, D., Bangma, C. H. & Roobol, M. J., Apr 1 2019, In : European urology. 75, 4, p. 558-561 4 p.

Research output: Contribution to journalArticle

Prostate
Prostatic Neoplasms
Reference Values
Health
Biopsy

Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial

Zhou, A. P., Bai, Y., Song, Y., Luo, H., Ren, X., Wang, X., Shi, B., Fu, C., Cheng, Y., Liu, J., Qin, S., Li, J., Li, H., Bai, X., Ye, D., Wang, J. & Ma, J., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalArticle

Phase II Clinical Trials
Renal Cell Carcinoma
Randomized Controlled Trials
Safety
Therapeutics